Abbott announced that its new FreeStyle InsuLinx Blood Glucose Monitoring System is now available in diabetes centres and select pharmacies across Canada. It is the first blood glucose monitoring device in North America that offers a mealtime insulin calculator for calculating suggested insulin doses.

The FreeStyle InsuLinx System is designed to offer suggested insulin doses, as well as other features specifically intended to assist insulin-using patients in more effectively managing their diabetes. The user-friendly features include a touch screen interface, automated logbook, personalization preferences, and USB connectivity for plug-and-play reports.

More than three million Canadians are living with diabetes and many of them require insulin to manage their condition. For those who use insulin, managing diabetes can often involve challenging calculations to determine an appropriate mealtime insulin dose. In a diabetes survey conducted in October 2011 by Leger Marketing, 200 Canadian healthcare professionals -- including general practitioners, diabetes nurse educators and endocrinologists -- stated that, in their respective clinics, four in ten mealtime insulin-using patients had difficulty calculating a mealtime insulin dose. Virtually all health care professionals (HCPs) surveyed (97%) believe that a patient's inability to manage insulin therapy limits the intensity and complexity of the therapy that an HCP can prescribe or recommend.

To read complete release click here

For more information :